(Q42175087)

18 October 2017

Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice (English)

1 reference

18 October 2017

1 reference

1 reference

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Christian Wetterauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Tatjana Vlajnic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Julia Schüler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Joel R Gsponer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

George N Thalmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Marco Cecchini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Julia Schneider

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Tobias Zellweger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Heike Pueschel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Alexander Bachmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Christian Ruiz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Stephan Dirnhofer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Lukas Bubendorf

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

13 January 2015

1 reference

18 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

585-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25585936%20AND%20SRC:MED&resulttype=core&format=json

Patient-derived tumor xenografts: transforming clinical samples into mouse models

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Molecular mechanisms of castration-resistant prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Human prostate cancer heterotransplants: a review on this experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Breaking through a roadblock in prostate cancer research: an update on human model systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Current mouse and cell models in prostate cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Next generation patient-derived prostate cancer xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Development and characterization of efficient xenograft models for benign and malignant human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Brief report: a bioassay to identify primary human prostate cancer repopulating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

BM18: A novel androgen-dependent human prostate cancer xenograft model derived from a bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Establishment and genomic characterization of mouse xenografts of human primary prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Epstein-Barr virus infection and posttransplant lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Epstein-Barr virus-recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

Humanized mice in translational biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22939